NCT02006342View on ClinicalTrials.gov

Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Diabetic Ketoacidosis
Interventions
DRUG

Insulin Glargine

DRUG

Regular Insulin

Trial Locations (2)

77026

Lyndon B Johnson Hospital, Houston

77030

Memorial Herman Hospital-Texas Medical Center, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02006342 - Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis | Biotech Hunter | Biotech Hunter